Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
Financial Results:
- Indoco Remedies Ltd reported Revenues for Q2FY24 of ₹482.00 Crores up from ₹433.00 Crore year on year, a rise of 11.32%.
- Total Expenses for Q2FY24 of ₹439.00 Crores up from ₹366.00 Crores year on year, a rise of 19.95%.
- Consolidated Net Profit of ₹35.00 Crores down 30.0% from ₹50.00 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹3.81, down 29.44% from ₹5.40 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.